Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii

Experimental Parasitology

Volumn 120, Issue 3, 2008, Pages 227-234

  Costa Silva, Thais A ^a   Meira, Cristina S ^a   Ferreira, Isabelle M R ^a   Hiramoto, Roberto M ^a   Pereira Chioccola, Vera L ^a  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

Author keywords

A Sn inbred mice; Excreted secreted tachyzoite antigens; Immunization; Toxoplasma gondii

Indexed keywords

EXCRETORY SECRETORY ANTIGEN; EXCRETORY SECRETORY ANTIGEN ANTIBODY; PARASITE ANTIBODY; PARASITE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; INBRED STRAIN; INFECTION SENSITIVITY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SURVIVAL; TACHYZOITE; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; COMPLEMENT SYSTEM PROTEINS; DISEASE MODELS, ANIMAL; DNA, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IMMUNIZATION; IMMUNOBLOTTING; MICE; MICE, INBRED C57BL; PARASITEMIA; POLYMERASE CHAIN REACTION; PROTOZOAN PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL;

ANIMALIA; MUS; OVIS ARIES; TOXOPLASMA GONDII;

EID: 53049102886     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2008.07.015     Document Type: Article

References (46)

1. Angus C.W., Klivington-Evans D., Dubey J.P., and Kovacs J.A. Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents. The Journal of Infectious Diseases 181 (2000) 317-324
2. Araújo A.F., Alencar B.C., Vasconcelos J.R., Hiyane M.I., Marinho C.R., Penido M.L., Boscardin S.B., Hoft D.F., Gazzinelli R.T., and Rodrigues M.M. CD8+-T-cell dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein. Infection and Immunity 73 (2005) 6017-6025
3. Burg J.L., Grove C.M., Pouletty P.J., and Boothroyd J.C. Directed and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. Journal of Clinical Microbiology 27 (1989) 1787-1792
4. Buxton D. Protozoan infections (Toxoplasma gondii, Neospora caninum and Sarcocystis spp.) in sheep and goats: recent advances. Veterinary Research 29 (1998) 289-310
5. Buxton D., and Innes E.A. A commercial vaccine for ovine toxoplasmosis. Review. Parasitology 110 Suppl. (1995) S11-S16
6. Camargo M.E., and Leser P.G. Diagnostic information from serological tests in human toxoplasmosis. II. Evaluative study of antibodies and serological patterns in acquired toxoplasmosis, as detected by hemagglutination, complement fixation, IgG and IgM immunofluorescence tests. Revista do Instituto de Medicina Tropical de São Paulo 18 (1976) 227-238
7. Carruthers V.B. Host cell invasion by the opportunistic pathogen Toxoplasma gondii. Acta Tropica 81 (2002) 111-122
8. Cesbron-Delauw M.F., and Capron A. Excreted-secreted antigens of Toxoplasma gondii: their origin and role in the host-parasite interaction. Research in Immunology 144 (1993) 41-44
9. Chen G.H., Guo H., Lu F., and Zheng H. Construction of a recombinant plasmid harboring the rhoptry protein 1 gene of Toxoplasma gondii and preliminary observation on DNA immunity. Chinese Medical Journal 114 (2001) 837-840
10. Colombo F.A., Vidal J.E., Penalva de Oliveira A.C., Hernández A.V., Bonasser-Filho F., Nogueira R.S., Focaccia R., and Pereira-Chioccola V.L. Diagnosis of cerebral toxoplasmosis in AIDS patients in Brazil: importance of molecular and immunological methods using peripheral blood samples. Journal of Clinical Microbiology 43 (2005) 5044-5047
11. Daryani A., Hosseine A.Z., and Dalimi A. Immune response against excreted/secreted antigens of Toxoplasma gondii tachyzoites in the murine model. Veterinary Parasitology 113 (2003) 123-134
12. Dimier-Poisson I., Aline F., Mévélec M.N., Beauvillain C., Buzoni-Gatel D., and Bout D. Protective mucosal Th2 immune response against Toxoplasma gondii by murine mesenteric lymph node dendritic cells. Infection and Immunity 71 (2003) 5254-5264
13. Dubey, J.P., 1996. Toxoplasma gondii. In: Baron, S., Peake, R.C., James, D.A., Susman, M., Kennedy, C.A., Singleton, M.J.D., Schuenke, S. (Eds.), Medical Microbiology, fifth ed. The University of Texas. Available from: .
14. Dubey J.P. Advances in the life cycle of Toxoplasma gondii. International Journal for Parasitology 7 (1998) 1019-1024
15. Duquesne V., Auriault C., Darcy F., Decavel J.P., and Capron A. Protection of nude rats against Toxoplasma infection by excreted-secreted antigen-specific helper T-cells. Infection and Immunity 58 (1990) 2120-2126
16. El-Malky M., Shaohong L., Kumagai T., Yabu Y., Noureldin M.S., Saudy N., Maruyama H., and Ohta N. Protective effect of vaccination with Toxoplasma lysate antigen and CpG as an adjuvant against Toxoplasma gondii in susceptible C57BL/6 mice. Microbiology and Immunology 49 (2005) 639-646
17. Ferreira I.M.R., Vidal J.E., Costa-Silva T.A., Meira C.S., Hiramoto R.M., Penalva de Oliveira A.C., and Pereira-Chioccola V.L. Toxoplasma gondii: genotyping of strains from Brazilian AIDS patients with cerebral toxoplasmosis by multilocus PCR-RFLP markers. Experimental parasitology 118 (2008) 221-227
18. Franchin G., Pereira-Chioccola V.L., Schenkman S., and Rodrigues M.M. Passive transfer of a monoclonal antibody specific for a sialic acid-dependent epitope on the surface of Trypanosoma cruzi trypomastigotes reduces infection in mice. Infection and Immunity 65 (1997) 2548-2554
19. Hill D.E., Chirukandoth S., and Dubey J.P. Biology and epidemiology of Toxoplasma gondii in man and animals. Animal Health Research Reviews 6 (2005) 41-61
20. Hiramoto R.M., Galisteo Jr. A.J., Nascimento N., and Andrade Jr. H.F. 200Gy sterilized Toxoplasma gondii tachyzoites maintain metabolic functions and mammalian cell invasion, eliciting cellular immunity and cytokine response similar to natural infection in mice. Vaccine 20 (2002) 2072-2081
21. Hoffmann, C., 2005. Opportunistic infections. In: Hoffmann, C., Rockstroh, J.K., Kamps, B.S. (Eds.), HIV Medicine Flying publisher. Available from: .
22. Ismael A.B., Sekkai D., Collin C., Bout D., and Meyelec M.N. The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis. Infection and Immunity 71 (2003) 6222-6228
23. Kang H., Remington J.S., and Suzuki Y. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNFalpha, and inducible nitric oxide synthase. The Journal of Immunology 164 (2000) 2629-2634
24. Kasper L.H. Isolation and characterization of a monoclonal anti-P30 antibody resistant mutant of Toxoplasma gondii. Parasite Immunology 9 (1987) 433-445
25. Lee Y.H., Shin D.W., Lee J.H., Nam H.W., and Ahn M.H. Vaccination against murine toxoplasmosis using recombinant Toxoplasma gondii SAG3 antigen alone or in combination with Quil A. Yonsei Medical Journal 48 (2007) 396-404
26. Liu K.Y., Zhang D.B., Wei Q.K., Li J., Li G.P., and Yu J.Z. Biological role of surface Toxoplasma gondii antigen in development of vaccine. World Journal of Gastroenterology 12 (2006) 2363-2368
27. Martin V., Supanitsky A., Echeverria P.C., Litwin S., Tanos T., De Roodt A.R., Guarnera E.A., and Angel S.O. Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis. Journal of Clinical Microbiology 11 (2004) 704-710
28. Meira C.S., Costa-Silva T.A., Vidal J.E., Ferreira I.M.R., Hiramoto R.M., and Pereira-Chioccola V.L. Use of the serum reactivity against Toxoplasma gondii excreted-secreted antigen in cerebral toxoplasmosis diagnosis in HIV-infected patients. Journal of Medical Microbiological 57 (2008) 845-850
29. Mévélec M.N., Merecerau-Puijalon O., Buzoni-Gatel D., Bourguin I., Chardes T., Dubremetz J.F., and Bout D. Mapping of B epitopes in GRA4, a dense granule antigen of Toxoplasma gondii and protection studies using recombinant proteins administered by the oral route. Parasite Immunology 20 (1998) 183-195
30. Montoya J.G., and Liesenfeld O. Toxoplasmosis. Lancet 363 (2004) 1965-1976
31. Pena H.F.J., Gennari S.M., Dubey J.P., and Su C. Population structure and mousevirulence of Toxoplasma gondii in Brazil. International Journal for Parasitology 38 (2008) 561-569
32. Pereira-Chioccola V.L., Costa F., Ribeirão M., Soares I.S., Arena F., Schenkman S., and Rodrigues M.M. Comparison of antibody and protective immune responses against Trypanosoma cruzi infection elicited by immunization with a parasite antigen delivered as naked DNA or recombinant protein. Parasite Immunology 21 (1999) 103-110
33. Petersen E., Nielsen H., Christiansen V.L., and Spenter J. Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii. Vaccine (1998) 16:1283-1289
34. Pietkiewicz H., Hiszczyńska-Sawicka E., Kur J., Petersen E., Nielsen H.V., Paul M., Stankiewicz M., and Myjak P. Usefulness of Toxoplasma gondii recombinant antigens (GRA1, GRA7 and SAG1) in an immunoglobulin G avidity test for the serodiagnosis of toxoplasmosis. Parasitology Research 100 (2007) 333-337
35. Prigione I., Facchetti P., Lecordier L., Deslee D., Chiesa S., Cesbron-Delauw M.F., and Pistoia V. T cell clones raised from chronically infected healthy humans by stimulation with Toxoplasma gondii excretory-secretory antigens cross-react with live tachyzoites: characterization of the fine antigenic specificity of the clones and implications for vaccine development. The Journal of Immunology 7 (2000) 3741-3748
36. Sambrook J., Fritsch E.F., and Maniatis T. Molecular cloning. A Laboratory Manual (1989), Cold Spring Harbour Laboratory Press, New York
37. Scheerlinck J.P., Casey G., McWaters P., Kelly J., Woollard D., Lightowlers M.W., Tennent J.M., and Chaplin P.J. The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy. Vaccine 19 (2001) 4053-4060
38. Soldati D., and Meissner M. Toxoplasma as a novel system for motility. Review. Current Opinion in Cell Biology 16 (2004) 32-40
39. Souza W. Secretory organelles of pathogenic protozoa. Anais da Academia Brasileira de Ciências 78 (2006) 271-291
40. Tilley M., Fichera M.E., Jerome M.E., Roos D.S., and White M.W. Toxoplasma gondii sporozoites from a transient parasitophorus vacuole that is impermeable and contains only a subset of dense granule proteins. Infection and Immunity 65 (1997) 4598-4605
41. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences of the United States of America 76 (1979) 4350-4357
42. Toxodb.org-ToxoDB: The Toxoplasma gondii genome resource. Available from: . (accessed February 2008).
43. Vasconcelos J.R., Boscardin S.B., Hiyane M.I., Kinoshita S.S., Fujimura A.E., and Rodrigues M.M. A DNA-priming protein-boosting regimen significantly improves type 1 immune response but not protective immunity to Trypanosoma cruzi infection in a highly susceptible mouse strain. Immunology and Cell Biology 81 (2003) 121-129
44. Vidal J.E., Colombo F.A., Penalva de Oliveira A.C., Focaccia R., and Pereira-Chioccola V.L. PCR assay using cerebrospinal fluid for diagnosis of cerebral toxoplasmosis in Brazilian AIDS patients. Journal of Clinical Microbiology 42 (2004) 4765-4768
45. Zenner L., Estaquier J., Darcy F., Maes P., Capron A., and Caesbron-Delauw M.F. Protective immunity in the rat model of congenital toxoplasmosis and the potential vaccinal role of excreted-secreted antigens (ESA). Parasite Immunology 21 (1999) 261-272
46. Zhou X.W., Kafsack B.F.C., Cole R.N., Beckett P., Shen R.F., and Carruthers V.B. The opportunistic pathogen Toxoplasma gondii deploys a diverse legion of invasion and survival proteins. The Journal of Biological Chemistry 280 (2005) 34233-34244